Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease

Authors: Jeffrey J. Cavendish¹; Michael Safani²

Source: Current Medical Research and Opinion, Volume 20, Number 11, November 2004 , pp. 1851-1855(5)

Buy & download fulltext article:

Price: $51.50 plus tax (Refund Policy)

Abstract:

Peripheral arterial disease (PAD) is a common manifestation of the atherosclerotic disease process, typically affecting vascular beds in the lower extremities. In its most severe form PAD may lead to limb amputation. Patients with PAD are also at increased cross-risk of thrombosis at coronary and cerebrovascular sites. However, despite its prevalence and severity, PAD is underdiagnosed and undertreated. In this collection of case studies, the role of the antiplatelet agent clopidogrel in current treatment strategies for the management of PAD is highlighted.

Keywords: ANTIPLATELET; CLAUDICATION; CROSS-RISK; PERIPHERAL ARTERIAL DISEASE

Document Type: Research article

DOI: http://dx.doi.org/10.1185/030079904X10683

Affiliations: 1: Department of Cardiology, Naval Medical Center, San Diego, CA, USA 2: Long Beach Memorial Medical Center, CA and Volunteer Faculty, University of California in San Francisco, Redondo Beach, CA, USA

Publication date: 2004-11-01

More about this publication?